← Leaderboards
Rhoel David Ramos Dinglasan
Johns Hopkins University
$28,554,044
Attributed
$35,848,212
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.3M · FY2006–25$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$20,799,629 · 3
NIH$16,542,829 · 15
By mechanism
U01$20,799,629 · 3
R01$10,002,354 · 4
U19$2,988,493 · 6
T32$2,309,326 · 1
R21$837,663 · 2
K22$269,863 · 1
Top collaborators
- Jonathan J Juliano14 shared
- Sandrine Nsango7 shared
- Hai-Quan Mao6 shared
- Peter C Agre5 shared
- Jay H. Bream5 shared
- Isabelle Coppens5 shared
- George Dimopoulos Dimopoulos5 shared
- Gregory E Glass5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Nirbhay Kumar$12,253,206
- Georgia J Michlig$495,906
Others in their field
Top investigators on “Malaria”
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Stephen Lev Hoffman · Sanaria, Inc.$79,440,588
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
Research focus
MalariaPlasmodium FalciparumParasitesMolecularCulicidaeTransmission ProcessCountryProteinsBaseInfectionAfricaInsightAnopheles GenusSamplingProgramsBiologyProteomicsVector MosquitoCameroonDiagnosticCentral AfricaPrevalenceAfrica South Of The SaharaAffect
Grant awards (62)
CK22-005 - CDC Southeastern Center of Excellence in Vector-Borne Diseases: Gateway Program$2,000,000
U01 · FY2025 · CK · contact PI
West-Central Africa EMERGENTS International Center of Excellence in Malaria Research (ICEMR)$747,123
U19 · FY2025 · AI · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$607,415
R01 · FY2025 · AI
Area B Transmission$323,454
U19 · FY2025 · AI · contact PI
Emergents International Centers of Excellence for Malaria Research$167,742
U19 · FY2025 · AI · contact PI
Area C Pathogenesis and Diagnosis$148,374
U19 · FY2025 · AI · contact PI
Emergents International Centers of Excellence for Malaria Research$97,214
U19 · FY2025 · AI · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$69,638
R01 · FY2025 · AI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$46,558
R01 · FY2025 · AI
Data Management Core$10,339
U19 · FY2025 · AI · contact PI
CDC Southeastern Center of Excellence in Vector-Borne Diseases: Gateway Program$2,000,000
U01 · FY2024 · CK · contact PI
West-Central Africa EMERGENTS International Center of Excellence in Malaria Research (ICEMR)$747,123
U19 · FY2024 · AI · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$693,422
R01 · FY2024 · AI
Area B Transmission$274,998
U19 · FY2024 · AI · contact PI
Emergents International Centers of Excellence for Malaria Research$179,895
U19 · FY2024 · AI · contact PI
Area C Pathogenesis and Diagnosis$169,176
U19 · FY2024 · AI · contact PI
Emergents International Centers of Excellence for Malaria Research$112,970
U19 · FY2024 · AI · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$77,596
R01 · FY2024 · AI
Data Management Core$10,085
U19 · FY2024 · AI · contact PI
CDC Southeastern Center of Excellence in Vector-Borne Diseases: Gateway Program$2,000,000
U01 · FY2023 · CK · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$649,572
R01 · FY2023 · AI
RFA-GH-21-006, SICA Study: Seroepidemiological Insight into COVID-19 transmission in Africa$1
U01 · FY2023 · GH · contact PI
CDC Southeastern Center of Excellence in Vector-Borne Diseases: Gateway Program$2,000,000
U01 · FY2022 · CK · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$680,820
R01 · FY2022 · AI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$664,108
R01 · FY2022 · AI
RFA-GH-21-006, SICA Study: Seroepidemiological Insight into COVID-19 transmission in Africa$500,000
U01 · FY2022 · GH · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$1,779
R01 · FY2022 · AI
SICA Study: Seroepidemiological Insight into COVID-19 transmission in Africa$2,000,000
U01 · FY2021 · GH · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$708,641
R01 · FY2021 · AI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$47,586
R01 · FY2021 · AI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$717,783
R01 · FY2020 · AI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$710,593
R01 · FY2019 · AI
A biodegradable nano-microparticle prime-boost vaccine strategy$310,823
R01 · FY2019 · AI · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$758,337
R01 · FY2018 · AI
A biodegradable nano-microparticle prime-boost vaccine strategy$281,266
R01 · FY2018 · AI · contact PI
Southeastern Regional CoE in Vector-Borne Diseases: The Gateway Program$200,000
U01 · FY2018 · CK · contact PI
Southeastern Regional CoE in Vector-Borne Diseases: The Gateway Program$100,000
U01 · FY2018 · CK · contact PI
Southeastern Regional CoE in Vector-Borne Diseases: The Gateway Program$9,999,628
U01 · FY2017 · CK · contact PI
A biodegradable nano-microparticle prime-boost vaccine strategy$306,671
R01 · FY2017 · AI · contact PI
A biodegradable nano-microparticle prime-boost vaccine strategy$244,987
R01 · FY2016 · AI · contact PI
A biodegradable nano-microparticle prime-boost vaccine strategy$97,869
R01 · FY2016 · AI · contact PI
Function and Mechanism of O-Fucosylation of Malaria ParasiteTSR Domain Proteins$73,544
R21 · FY2016 · AI · contact PI
Function and mechanism of O-fucosylation of malaria parasite TSR-domain proteins$59,919
R21 · FY2016 · AI · contact PI
A biodegradable nano-microparticle prime-boost vaccine strategy$405,000
R01 · FY2015 · AI · contact PI
Function and mechanism of O-fucosylation of malaria parasite TSR-domain proteins$250,130
R21 · FY2015 · AI · contact PI
Midgut Transcriptome and Proteome Analyses: Non-model Anopheline Malaria Vectors$240,232
R21 · FY2015 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$424,613
T32 · FY2014 · AI
Midgut Transcriptome and Proteome Analyses: Non-model Anopheline Malaria Vectors$213,838
R21 · FY2014 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$507,302
T32 · FY2013 · AI
Small molecule protein-glycan inhib. as malaria transmission-blocking therapuetic$377,731
R01 · FY2013 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$499,422
T32 · FY2012 · AI
Small molecule protein-glycan inhib. as malaria transmission-blocking therapuetic$401,841
R01 · FY2012 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$450,573
T32 · FY2011 · AI
Small molecule protein-glycan inhib. as malaria transmission-blocking therapuetic$401,841
R01 · FY2011 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$427,416
T32 · FY2010 · AI
Small molecule protein-glycan inhib. as malaria transmission-blocking therapuetic$360,486
R01 · FY2010 · AI · contact PI
Glycobiological Analysis of Plasmodium-Vector Host Interactions$107,863
K22 · FY2010 · AI · contact PI
Small molecule protein-glycan inhib. as malaria transmission-blocking therapuetic$379,991
R01 · FY2009 · AI · contact PI
Glycobiological Analysis of Plasmodium-Vector Host Interactions$162,000
K22 · FY2009 · AI · contact PI
Plasmodium carbohydrate receptors in Anopheles gambiae$35,906
F32 · FY2008 · AI · contact PI
Plasmodium carbohydrate receptors in Anopheles gambiae$50,428
F32 · FY2007 · AI · contact PI
Plasmodium carbohydrate receptors in Anopheles gambiae$48,796
F32 · FY2006 · AI · contact PI